Key result
Self-expanding TAVI in small surgical valves maintains ~86% of survivors in functional class I or II.
Why the study?
Does self-expanding TAVI provide sufficient valve function and symptom relief in patients with small body size and small surgical aortic prostheses?
Observational
Does self-expanding TAVI provide sufficient valve function and symptom relief in patients with small body size and small surgical aortic prostheses?
Self-expanding TAVI provides sufficient valve function and symptom relief in patients with small body size and small initial surgical prostheses.
Answers are grounded in this paper and cite their sources.
May support feasibility in select patients with small prostheses; leaves open need for prospective trials before practice change.
, excluding 3 cases of off-label use and 3 cases of balloon-expandable valves. At the time of last follow-up, 86.2% of survivors remained in NYHA I or II.ConclusionsSelf-expanding TAVI in a certain type of SAVR provided sufficient valve function in a population with small body size, even after small-sized initial surgical prostheses. Surgeons need to ensure that the proper type and size of surgical prosthesis are implanted.
No takes yet. Share an insight, caveat, or question.
Kitamura et al. (2025) conducted an observational in Small surgical aortic prosthesis in small body size patients. Self-expanding transcatheter aortic valve implantation (TAVI) was evaluated on NYHA functional class I or II. Self-expanding TAVI in small surgical aortic prostheses provided sufficient valve function, with 86.2% of survivors remaining in functional class I or II at last follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: